Page 30 - பிரிட்டன் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3 Min Read SEOUL (Reuters) - South Korea on Wednesday said it would grant its first approval for a coronavirus vaccine to AstraZeneca, and will allow use in people 65 years or older, despite advisory panels’ warning of a lack of data on its efficacy for the elderly Slideshow ( 2 images ) Regulators will grant AstraZeneca’s vaccine emergency authorisation under the condition the company must submit its full clinical trial results, Vice Health Minister Kim Gang-lip told a news conference. “However, we have added a precautionary line for cautious decision for use of the shots the elderly aged 65 and older,” Kim said. Several European countries have warned that the shot should only be given to those ages 18 to 64, and such concerns had threatened to upend South Korea’s plan to prioritise elderly residents and medical workers in the first round of vaccinations.

United kingdomSoult ukpyolsiSouth koreaUnited statesJosh smithChristopher cushingSangmi chaThomson reuters trust principlesVice healthBritain oxford universityPrevention agencyVice health minister kim gang lipOxford universityKorea disease controlSouth africanLunar new year